drugset / Trial / NCT00484601
Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This research is to test the effectiveness and toxicity of both Ifosfamide and Doxorubicin. It also aims to explore the relationship between EBV DNA and clinical response in patients with advanced naso-pharyngeal cancer which has been previously treated with chemotherapy.
Timeline
- Start
- 2004-04-15
- Primary completion
- 2007-11-07
- Completion
- 2007-11-07
Outcome
Outcome not reported
Stopped (Enrollment): “Low accrual.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Ifosfamide | Small molecule | — | — |